Search hospitals > Illinois > O'Fallon
Memorial Hospital East
Claim this profileO'Fallon, Illinois 62269
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Tumors
Conducts research for Recurrence
Conducts research for Lymphoma
35 reported clinical trials
21 medical researchers
Summary
Memorial Hospital East is a medical facility located in O'Fallon, Illinois. This center is recognized for care of Cancer, Breast Cancer, Tumors, Recurrence, Lymphoma and other specialties. Memorial Hospital East is involved with conducting 35 clinical trials across 94 conditions. There are 21 research doctors associated with this hospital, such as Saiama N. Waqar, Amanda Cashen, MD, Kian-Huat Lim, M.D., Ph.D., and Jiayi Huang, M.D..Area of expertise
1Cancer
Global LeaderStage IV
ER positive
Stage III
2Breast Cancer
ER positive
PR positive
HER2 negative
Top PIs
Saiama N. WaqarWashington University School of Medicine2 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
23 reported clinical trials
47 drugs studied
Amanda Cashen, MDWashington University School of Medicine1 year of reported clinical research
Studies Acute Myeloid Leukemia
Studies Lymphoma
20 reported clinical trials
34 drugs studied
Kian-Huat Lim, M.D., Ph.D.Washington University School of Medicine6 years of reported clinical research
Studies Pancreatic Cancer
Studies Adenocarcinoma
22 reported clinical trials
47 drugs studied
Jiayi Huang, M.D.Washington University School of Medicine2 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
18 reported clinical trials
35 drugs studied
Clinical Trials running at Memorial Hospital East
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Cancer
Esophageal Carcinoma
Lung Cancer
Prostate Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Hospital East?
Memorial Hospital East is a medical facility located in O'Fallon, Illinois. This center is recognized for care of Cancer, Breast Cancer, Tumors, Recurrence, Lymphoma and other specialties. Memorial Hospital East is involved with conducting 35 clinical trials across 94 conditions. There are 21 research doctors associated with this hospital, such as Saiama N. Waqar, Amanda Cashen, MD, Kian-Huat Lim, M.D., Ph.D., and Jiayi Huang, M.D..